Two years after a widespread crackdown on dishonest research analysts, Wachovia Capital Markets LLC has agreed to shell out $25 million to settle state regulators' charges of conflicts of interest between the company's research and investment banking operations.
A subsidiary of Johnson & Johnson has filed a federal patent infringement lawsuit in an attempt to thwart a Canadian pharmaceutical company’s efforts to introduce a generic version of Risperdal, the latest in a series of suits filed by J&J to protect the market for its blockbuster antipsychotic drug.
In the latest blow to KPMG LLP, a court has greenlighted a lawsuit against the Big Four accounting firm brought by shareholders of a fraud-ridden company that lapsed into bankruptcy after KPMG, the company’s auditor, failed to perform proper audits.
Diebold Election Systems is facing a patent infringement battle with rival Avante International Technology Corp. over voting machines that gained notoriety in the last presidential campaign.
Drug makers Novartis Pharmaceuticals and Mylan Pharmaceuticals will meet in court over the patents for breast cancer treatment Femara, after an Abbreviated New Drug Application prompted Novartis to slap the generics maker with a lawsuit.
The brokerage units of three of the world’s largest securities firms—Merrill Lynch & Co., Morgan Stanley and Lehman Bros. Holdings Inc.—are taking Web site theflyonthewall.com to court, alleging that the online provider of financial news is infringing on the firms’ proprietary equity research.
A trial has begun in California in one of a plethora of big-dollar lawsuits against pharmaceutical giant Merck & Co. over the company's former-blockbuster drug Vioxx.
The Justice Department may have driven two major Mid-Atlantic utilities to sell several plants by filing a suit Thursday that threatens to derail their $16 billion merger.
A federal court in Georgia thwarted an attempt by River’s Edge Pharmaceuticals LLC to move in on the market for Nicomide, dismissing a lawsuit that challenged the validity of the patent covering the drug, which treats inflammatory skin disorders.
UnitedHealth Group is trying to stave off yet another lawsuit, challenging the investigation that the Minnesota Attorney General launched earlier this month into possible stock option grants and backdating.
Home Depot Inc. has joined the growing list of companies embroiled in questions about options practices, revealing that executives on three occasions were awarded options at below-market prices.
Saint Barnabas Health Care System has agreed to fork over $265 million to settle allegations that it defrauded Medicare out of more than half a billion dollars over an eight-year period.
The flood of federal probes into options backdating continued this week, as three more companies received inquiries from the U.S. Securities and Exchange Commission.
Memory chip companies Mosaid Technologies Inc. and Infineon Technologies AG settled two patent infringement lawsuits Wednesday, putting an end to an acrimonious battle fought for years in courtrooms on both coasts.
Under fire from all sides, the Vonage Holdings Corp. initial public offering has come under attack by the New York Stock Exchange this week, with the agency's regulatory unit sending a letter to brokerage firms inquiring about possible short sales of Vonage shares.
In the latest in New York State Attorney General Eliot Spizter’s probe into violations in the mutual fund industry, fund manager Fred Alger Management Inc. has agreed to shell out some $40 million to settle allegations it allowed illegal trading of its mutual fund shares.
The International Trade Commission plans to investigate whether drug maker Sanofi-Aventis violated patent laws in what has turned into a bittersweet struggle over an insulin delivery system patent between the French company and Danish drug maker Novo Nordisk A/S.
Attorneys for billionaire and majority shareholder Carl Icahn’s are seeking a protective order that would thwart efforts by the unsecured creditors committee of bankrupt gaming company GB Holdings Inc. to have Icahn and three other individuals deposed in the company’s Chapter 11 proceedings.
The legal onslaught caused by allegations of options backdating is just beginning for healthcare provider UnitedHealth Group. After being hit with several class action suits and a U.S. Securities and Exchange Commission investigation, the company may now face charges by the state of Minnesota.
The California Public Employee’s Retirement System has appealed a decision that removed the New York Stock Exchange as a defendant in a lawsuit alleging that the exchange aided several investment banks in executing fraudulent trading schemes.